Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK256066 in Seasonal Allergic Rhinitis
NCT00430157Phase 2Completed
- Sponsor
- GSK
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of GSK256066 in seasonal allergic rhinitis (SAR), sponsored by GSK. Started Jan 2007; status: completed.
02
Drugs
GSK256066
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00430157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00430157.